zoledronic acid has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagchi, S; Cairo, C; Ghosh, A; Kottilil, S; Mondal, RK; Pauza, CD; Poonia, B; Romani, S | 1 |
| Abbate, I; Agrati, C; Alonzi, T; Capobianchi, MR; Castilletti, C; D'Offizi, G; De Santis, R; Fimia, GM; Poccia, F; Siepi, F; Tripodi, M | 1 |
2 other study(ies) available for zoledronic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Persistent gamma delta T-cell dysfunction in chronic HCV infection despite direct-acting antiviral therapy induced cure.
Topics: Adult; Aged; Antiviral Agents; Cell Proliferation; Clinical Trials as Topic; Cohort Studies; Cytokines; Cytotoxicity Tests, Immunologic; Female; Hep G2 Cells; Hepatitis C, Chronic; Humans; Lymphocyte Activation; Male; Middle Aged; Phenotype; Receptors, Antigen, T-Cell, gamma-delta; Sustained Virologic Response; T-Lymphocytes; Zoledronic Acid | 2019 |
Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication.
Topics: Antigens; Bone Density Conservation Agents; Cell Line; Coculture Techniques; Diphosphonates; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Interferon-gamma; Lymphocyte Activation; Receptors, Antigen, T-Cell, gamma-delta; RNA, Viral; Th1 Cells; Virus Replication; Zoledronic Acid | 2006 |